Home » Topics » Immune, BioWorld Science

Immune, BioWorld Science
RSS

Three-dimensional structure of the T-cell receptor determined

Nov. 1, 1996

Takeda discloses vaccine candidates

Nov. 1, 1996

AM-94 available for licensing

Oct. 25, 1996

AM-101 available for licensing

Oct. 25, 1996

Procept seeks partners for immunosuppression, AIDS, CD2 programs

Oct. 25, 1996

Abbott to market North American Vaccine's DTaP and related vaccines

Oct. 25, 1996

Spotlight on antiinfective vaccine research in the U.S.

Oct. 18, 1996

New immunosuppressants disclosed by Merck & Co.

Oct. 18, 1996

Potential Chlamydia vaccine effective in preclinical studies

Oct. 18, 1996

University of Texas discloses OMPs for immunotherapy

Oct. 18, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...